Entera Bio Ltd reports results for the quarter ended in June - Earnings Summary

Entera Bio

14/08/2023 14:32

* Entera Bio Ltd  ENTX.OQ  reported a quarterly adjusted
loss
of 14 cents​​ per share for the quarter ended in June. The lone
analyst forecast for the quarter was for a loss of 7 cents per
share.
    * Reported revenue was zero​; analysts expected zero. 
    * Entera Bio Ltd's reported EPS for the quarter was a loss
of 16
cents​.
    * The mean earnings estimate of analysts was unchanged in
the last
three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Entera Bio Ltd shares had fallen by 12.3% this quarter and
gained 1.4% so far this year.
    * The company reported a quarterly loss of $4.52 million.
    * Wall Street's median 12-month price target for Entera Bio
Ltd is
$6.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data
August 14 at 01:32 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2023      -0.07          -0.14          Missed
 Mar. 31 2023      -0.12          -0.08          Beat
 Dec. 31 2022      -0.11          -0.10          Beat
 Sep. 30 2022      -0.13          -0.11          Beat